Istituzioni

Coronavirus (COVID-19) Update: Federal judge enters temporary injunction against Xephyr LLC doing business as N-Ergetics, preventing sale of Colloidal Silver Products for COVID-19

Food and Drug Administration - Gi, 14/05/2020 - 22:34
Federal judge enters temporary injunction against Xephyr LLC doing business as N-Ergetics, preventing sale of Colloidal Silver Products for COVID-19
Categorie: Istituzioni

FDA issues warning letters to two breast implant manufacturers as part of ongoing efforts to protect patients

Food and Drug Administration - Gi, 14/05/2020 - 21:27
FDA issued warning letters to two breast implant manufacturers for failure to comply with various regulatory requirements.
Categorie: Istituzioni

Coronavirus (COVID-19) Update: Daily Roundup May 13, 2020

Food and Drug Administration - Me, 13/05/2020 - 22:10
Coronavirus (COVID-19) Update: Daily Roundup
Categorie: Istituzioni

Coronavirus (COVID-19) Update: Daily Roundup May 12, 2020

Food and Drug Administration - Ma, 12/05/2020 - 23:20
Coronavirus (COVID-19) Update: Daily Roundup
Categorie: Istituzioni

Coronavirus (COVID-19) Update: FDA Takes New Actions to Accelerate Development of Novel Prevention, Treatment Options for COVID-19

Food and Drug Administration - Ma, 12/05/2020 - 01:34
FDA is taking important actions to help accelerate the development of prevention and treatment options for COVID-19 by providing new guidance with recommendations for innovators and researchers conducting work in this area.
Categorie: Istituzioni

Coronavirus (COVID-19) Update: FDA updates on surveillance inspections during COVID-19

Food and Drug Administration - Ma, 12/05/2020 - 00:58
FDA updates on surveillance inspections during COVID-19
Categorie: Istituzioni

Coronavirus (COVID-19) Update: Daily Roundup May 11, 2020

Food and Drug Administration - Ma, 12/05/2020 - 00:42
Coronavirus (COVID-19) Update: Daily Roundup
Categorie: Istituzioni

Coronavirus (COVID-19) Update: FDA Authorizes First Antigen Test to Help in the Rapid Detection of the Virus that Causes COVID-19 in Patients

Food and Drug Administration - Sa, 09/05/2020 - 17:10
The U.S. Food and Drug Administration has issued the first emergency use authorization (EUA) for a COVID-19 antigen test, a new category of tests for use in the ongoing pandemic.
Categorie: Istituzioni

Coronavirus (COVID-19) Update: Daily Roundup May 8, 2020

Food and Drug Administration - Sa, 09/05/2020 - 00:23
Coronavirus (COVID-19) Update: Daily Roundup
Categorie: Istituzioni

FDA Approves First Therapy for Patients with Lung and Thyroid Cancers with a Certain Genetic Mutation or Fusion

Food and Drug Administration - Ve, 08/05/2020 - 22:42
FDA approves Retevmo (selpercatinib) capsules to treat three types of tumors, non-small cell lung cancer, medullary thyroid cancer and other thyroid cancers, in patients whose tumors have an RET gene alteration.
Categorie: Istituzioni

Coronavirus (COVID-19) Update: FDA Authorizes First Diagnostic Test Using At-Home Collection of Saliva Specimens

Food and Drug Administration - Ve, 08/05/2020 - 17:39
Today, the U.S. Food and Drug Administration authorized the first diagnostic test with the option of using home-collected saliva samples for COVID-19 testing
Categorie: Istituzioni

Coronavirus (COVID-19) Update: Daily Roundup May 7, 2020

Food and Drug Administration - Ve, 08/05/2020 - 01:34
Coronavirus (COVID-19) Update: Daily Roundup
Categorie: Istituzioni

Coronavirus (COVID-19) Update: FDA Continues to Combat Fraudulent COVID-19 Medical Products

Food and Drug Administration - Gi, 07/05/2020 - 15:24
FDA provides an update on its efforts to combat COVID-19 fraud
Categorie: Istituzioni

Coronavirus (COVID-19) Update: Daily Roundup May 6, 2020

Food and Drug Administration - Me, 06/05/2020 - 23:22
Coronavirus (COVID-19) Update: Daily Roundup
Categorie: Istituzioni

FDA Approves First Targeted Therapy to Treat Aggressive Form of Lung Cancer

Food and Drug Administration - Me, 06/05/2020 - 20:40
FDA approves Tabrecta (capmatinib) for the treatment of adult patients with non-small cell lung cancer (NSCLC) that has spread. Tabrecta is the first FDA-approved therapy to treat NSCLC with specific MET exon 14 skipping mutations.
Categorie: Istituzioni

Coronavirus (COVID-19) Update: Daily Roundup May 5, 2020

Food and Drug Administration - Me, 06/05/2020 - 02:10
Coronavirus (COVID-19) Update: Daily Roundup
Categorie: Istituzioni

FDA approves new treatment for a type of heart failure

Food and Drug Administration - Me, 06/05/2020 - 01:13
FDA approves treatment for heart failure with reduced ejection fraction
Categorie: Istituzioni

Coronavirus (COVID-19) Update: Daily Roundup May 4, 2020

Food and Drug Administration - Lu, 04/05/2020 - 23:57
Coronavirus (COVID-19) Update: Daily Roundup
Categorie: Istituzioni

Coronavirus (COVID-19) Update: Daily Roundup May 1, 2020

Food and Drug Administration - Sa, 02/05/2020 - 01:48
Coronavirus (COVID-19) Update: Daily Roundup
Categorie: Istituzioni

Coronavirus (COVID-19) Update: FDA Issues Emergency Use Authorization for Potential COVID-19 Treatment

Food and Drug Administration - Ve, 01/05/2020 - 22:08
FDA has issued emergency use authorization for the investigational antiviral drug remdesivir for the treatment of suspected or laboratory-confirmed COVID-19 in adults and children hospitalized with severe disease.
Categorie: Istituzioni
Condividi contenuti